The Journal of Shahid Sadoughi University of Medical Sciences
مجله علمي پژوهشي دانشگاه علوم پزشكي شهید صدوقی يزد
JSSU
Medical Sciences
http://jssu.ssu.ac.ir
20
journal20
2228-5741
2228-5733
fa
jalali
1404
4
1
gregorian
2025
7
1
33
4
online
1
fulltext
fa
تاثیر پروتکل تمرین عملکردی با شدت بالا همراه با مکمل یاری جینکوبیلوبا بر وضعیت آنتیاکسیدانی مردان آتشنشان رسته عملیاتی شهر یزد
Effect of High-Intensity Functional Training Protocol Combined with Ginkgo Biloba SuPPlementation on the Antioxidant Status of Male Firefighters in the OPerational Division of Yazd City
فیزیولوژی ورزش
Exercise Physiology
پژوهشي
Original article
<div style="text-align: justify;"><span style="font-size:11pt"><span style="line-height:18.0pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span calibri="" style="font-family:"><b><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">مقدمه:</span></span></b> <span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">مطالعات نشان می­دهد که </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">استرس فیزیولوژیکی با اختلال در وضعیت آنتیاکسیدانی بدن موجب بروز آسیب­های بافتی و سلولی می­شود. هدف </span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">از </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">تحقیق حاضر بررسی تاثیر 12 هفته تمرین عملکردی با شدت بالا (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">HIFT</span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">) و مکمل یاری</span></span> <span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">جینکوبیلوبا</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">Gb</span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> بر سطوح سرمی سوپراکسید دیسموتاز (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">SOD</span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)، کاتالاز (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">CAT</span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">) و ظرفیت آنتیاکسیدانی تام (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">TAC</span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">) در مردان آتشنشان رسته عملیاتی شهر یزد بود</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">.</span></span><span lang="FA" style="font-size:12.0pt"><span style="font-family:"B Nazanin""></span></span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:18.0pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span calibri="" style="font-family:"><b><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">روش بررسی:</span></span></b> <span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">در این مطالعه نیمه تجربی، 48 م</span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">رد </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">آتشنشان به</span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">طور تصادفی در چهار گروه شامل </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">تمرین عملکردی با شدت بالا (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">HIFT</span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">تمرین عملکردی با شدت بالا همراه </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">با مصرف </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">جینکوبیلوبا (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">HIFT+Gb</span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، مصرف </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">جینکوبیلوبا</span></span> <span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">(</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">Gb</span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">) </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">و کنترل- دارونما</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> (</span></span><span dir="LTR" new="" roman="" style="font-family:" times="">P-C</span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span> <span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">قرار گرفتند. پروتکل </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">تمرین </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">به مدت 12 هفته و هفتهای چهار جلسه انجام شد. مصرف </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">جینکوبیلوبا (80 میلیگرم) بهصورت دو کپسول و یک بار در روز بعد از صبحانه به مدت 12 هفته تجویز شد. نمونه­گیری قبل و 48 ساعت پس از آخرین جلسه مداخله انجام شد. دادهها با استفاده از آزمون تحلیل واریانس </span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">با اندازه­­گیری مکرر، تحلیل واریانس یک­راهه و </span></span><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">دوراهه با نرمافزار </span></span><span dir="LTR" new="" roman="" style="font-family:" times="">version 16</span> <span dir="LTR" new="" roman="" style="font-family:" times="">SPSS</span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> تجزیه و تحلیل شدند.</span></span><span lang="FA" style="font-size:12.0pt"><span style="font-family:"B Nazanin""></span></span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:18.0pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span calibri="" style="font-family:"><b><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">نتایج:</span></span></b><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> در پایان 12 هفته مداخله، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">SOD</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">CAT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">TAC</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> گروه</span></span><span lang="FA" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""></span><span b="" nazanin="" style="font-family:">های (0/0001<b>=</b></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">HIFT</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، (0/0001<b>=</b></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">) </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">HIFT+Gb </span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و (0/0001<b>=</b></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span> <span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">Gb</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> به طور معناداری نسبت به گروه </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P-C</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> افزایش یافت. </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">SOD</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">CAT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">TAC</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> گروه</span></span><span lang="FA" style="font-size:12.0pt"><span new="" roman="" style="font-family:" times=""></span><span b="" nazanin="" style="font-family:">های</span></span> <span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">(0/0001<b>=</b></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times=""> HIFT</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">و (0/0001<b>=</b></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times=""> HIFT+Gb</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> نسبت به گروه </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">Gb</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> افزایش معناداری داشت. </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">SOD</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">CAT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">TAC</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> گروه</span></span> <span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">(0/0001<b>=</b></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">)</span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times=""> HIFT </span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">نسبت به گروه </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">HIFT+Gb</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> بهطور معناداری افزایش داشت. اثر توام </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">HIFT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> همراه با </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">Gb</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> بهطور معناداری سطوح سرمی </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">SOD</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">CAT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">TAC</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> را افزایش داد (0/05></span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">P</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">). بیشترین درصد تغییرات ایجاد شده در </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">SOD</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">CAT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">TAC</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> به دنبال مداخله </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">HIFT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> همراه با مصرف </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">Gb</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> مشاهده شد.</span></span> <span lang="FA" style="font-size:12.0pt"><span style="font-family:"B Nazanin""></span></span></span></span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:18.0pt"><span style="direction:rtl"><span style="unicode-bidi:embed"><span calibri="" style="font-family:"><b><span lang="AR-SA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">نتیجهگیری:</span></span></b> <span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">تاثیر ترکیبی 12 هفته </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">HIFT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> همراه با مصرف جینکوبیلوبا در مقایسه با اثر اصلی هر کدام، بیشترین تأثیر را بر افزایش سطوح سرمی </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">SOD</span></span><span lang="FA" style="font-size:12.0pt"><span b="" nazanin="" style="font-family:">، </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">CAT</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و </span></span><span dir="LTR" style="font-size:10.0pt"><span new="" roman="" style="font-family:" times="">TAC</span></span><span style="font-size:12.0pt"><span b="" nazanin="" style="font-family:"> و بهبود شرایط استرس اکسیداتیو در آتشنشانان داشت.</span></span></span></span></span></span></span></div>
<div style="text-align: justify;"><span style="font-size:11pt"><span style="line-height:15.0pt"><span calibri="" style="font-family:"><b><span new="" roman="" style="font-family:" times="">Introduction:</span></b><span new="" roman="" style="font-family:" times=""> Research indicates that Physiological stress leads to tissue and cellular damage through its disruPtion of antioxidant status in the body. The main objective of this research was to determine the effects of 12 weeks of high-intensity functional training (HIFT) and Ginkgo biloba (Gb) suPPlementation on suPeroxide dismutase (SOD), catalase (CAT) and total antioxidant caPacity (TAC) serum levels in male firefighters of the oPerational division of Yazd City.</span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:15.0pt"><span calibri="" style="font-family:"><b><span new="" roman="" style="font-family:" times="">Methods:</span></b><span new="" roman="" style="font-family:" times=""> In this semi-exPerimental study, 48 male firefighters were randomly divided into four grouPs: high-intensity functional training (HIFT), high-intensity functional training combined with ginkgo biloba suPPlementation (HIFT+Gb), ginkgo biloba extract alone (Gb), and a control Placebo grouP (P-C). The training Program lasted 12 weeks, with ParticiPants training four times Per week. The ginkgo biloba suPPlement (80 mg) was administered in two caPsules daily after breakfast for the entire 12-week Period. Blood samPles were taken before the start and 48 hours after the last training session. The collected data were analyzed using rePeated measures ANOVA, as well as one-way and two-way ANOVA in SPSS version 16.</span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:15.0pt"><span calibri="" style="font-family:"><b><span new="" roman="" style="font-family:" times="">Results:</span></b><span new="" roman="" style="font-family:" times=""> After 12 weeks of intervention, SOD, CAT, and TAC in the HIFT (P=0.0001), HIFT+Gb (P=0.0001), and Gb (P=0.0001) grouPs showed a significant increase comPared to the P-C grouP. SOD, CAT, and TAC levels in the HIFT (P=0.0001) and HIFT+Gb (P=0.0001) grouPs significantly rose when comPared to the Gb grouP. SOD, CAT, and TAC levels in the HIFT grouP (P=0.0001) were notably elevated in comParison to the HIFT+Gb grouP. The synergistic influence of HIFT with Gb markedly elevated serum concentrations of SOD, CAT, and TAC (P<0.05). The greatest Percentage of alterations in SOD, CAT, and TAC were noted after the HIFT intervention with Gb</span></span></span></span><br>
<span style="font-size:11pt"><span style="line-height:15.0pt"><span calibri="" style="font-family:"><b><span new="" roman="" style="font-family:" times="">Conclusion:</span></b><span new="" roman="" style="font-family:" times=""> The combined imPact of 12 weeks of HIFT Paired with Ginkgo biloba intake, in comParison to the individual effect of each, significantly enhanced serum levels of SOD, CAT, and TAC while ameliorating oxidative stress conditions in firefighters.</span></span></span></span><br>
</div>
برنامه تمرینی, جینکوبیلوبا, آنتیاکسیدان, مردان آتشنشان
Training Program, Ginkgo biloba, Antioxidant, OPerational firefighters.
8946
8960
http://jssu.ssu.ac.ir/browse.php?a_code=A-10-5434-1&slc_lang=fa&sid=1
Hamid
Sedaghat
حمید
صداقت
hsedaghat9194@gmail.com